• British Pharmacopoeia Volume I & II
  • Monographs: Medicinal and Pharmaceutical Substances

Bromhexine Hydrochloride

European Union chaplet of stars
scroll to previous hit
scroll to next hit
General Notices

(Ph Eur monograph 0706)

bp2013_v1_07_medicinal_and_pharmaceutical_substances_02 bromhexinehydrochloride_1_2012_70_cs.png


C14H20Br2N2,HCl    412.6    611-75-6

Action and use

Mucolytic.

Ph Eur

DEFINITION

N-(2-Amino-3,5-dibromobenzyl)-N-methylcyclohexanamine hydrochloride.

Content

98.5 per cent to 101.5 per cent (dried substance).

CHARACTERS
Appearance

White or almost white, crystalline powder.

Solubility

Very slightly soluble in water, slightly soluble in alcohol and in methylene chloride.

It shows polymorphism (5.9).

IDENTIFICATION

First identification   A, E.

Second identification   B, C, D, E.

A. Infrared absorption spectrophotometry (2.2.24).

Comparison   bromhexine hydrochloride CRS.

If the spectra obtained in the solid state show differences, dissolve the substance to be examined and the reference substance separately in methanol R, evaporate to dryness and record new spectra using the residues.

B. Thin-layer chromatography (2.2.27).

Test solution  Dissolve 20 mg of the substance to be examined in methanol R and dilute to 10 mL with the same solvent.

Reference solution  Dissolve 20 mg of bromhexine hydrochloride CRS in methanol R and dilute to 10 mL with the same solvent.

Plate  TLC silica gel F254 plate R.

Mobile phase  glacial acetic acid R, water R, butanol R (17:17:66 V/V/V).

Application  20 µL.

Development  Over 3/4 of the plate.

Drying  In air.

Detection  Examine in ultraviolet light at 254 nm.

Results  The principal spot in the chromatogram obtained with the test solution is similar in position and size to the principal spot in the chromatogram obtained with the reference solution.

C. Dissolve about 25 mg in a mixture of 1 mL of dilute sulfuric acid R and 50 mL of water R. Add 2 mL of methylene chloride R and 5 mL of chloramine solution R and shake. A brownish-yellow colour develops in the lower layer.

D. Dissolve about 1 mg in 3 mL of 0.1 M hydrochloric acid. The solution gives the reaction of primary aromatic amines (2.3.1).

E. Dissolve about 20 mg in 1 mL of methanol R and add 1 mL of water R. The solution gives reaction (a) of chlorides (2.3.1).

TESTS
Appearance of solution

The solution is clear (2.2.1) and not more intensely coloured than reference solution Y6 (2.2.2, Method II).

Dissolve 0.6 g in methanol R and dilute to 20 mL with the same solvent.

Related substances

Liquid chromatography (2.2.29).

Test solution  Dissolve 50 mg of the substance to be examined in methanol R and dilute to 10.0 mL with the same solvent.

Reference solution (a)  Dissolve 5 mg of bromhexine impurity C CRS in methanol R, add 1.0 mL of the test solution and dilute to 10.0 mL with the same solvent.

Reference solution (b)  Dilute 1.0 mL of the test solution to 100.0 mL with methanol R. Dilute 1.0 mL of this solution to 10.0 mL with methanol R.

Column:
  • size: l = 0.12 m, Ø = 4.6 mm,

Mobile phase  Mix 0.50 mL of phosphoric acid R in 950 mL of water R, adjust to pH 7.0 with triethylamine R (about 1.5 mL) and dilute to 1000 mL with water R; mix 20 volumes of this solution with 80 volumes of acetonitrile R.

Flow rate  1.0 mL/min.

Detection  Spectrophotometer at 248 nm.

Injection  10 µL.

Run time  2.5 times the retention time of bromhexine.

Relative retention  With reference to bromhexine (retention time = about 11 min): impurity A = about 0.1; impurity B = about 0.2; impurity C = about 0.4; impurity D = about 0.5.

System suitability  Reference solution (a):

  • resolution: minimum 12.0 between the peaks due to impurity C and bromhexine.
Limits:
  • any impurity: not more than twice the area of the principal peak in the chromatogram obtained with reference solution (b) (0.2 per cent), and not more than 1 such peak has an area greater than the area of the principal peak in the chromatogram obtained with reference solution (b) (0.1 per cent),
  • total: not more than 3 times the area of the principal peak in the chromatogram obtained with reference solution (b) (0.3 per cent),
  • disregard limit: 0.5 times the area of the principal peak in the chromatogram obtained with reference solution (b) (0.05 per cent).
Loss on drying (2.2.32)

Maximum 1.0 per cent, determined on 1.000 g by drying in an oven at 105 °C.

Sulfated ash (2.4.14)

Maximum 0.1 per cent, determined on 1.0 g.

ASSAY

Dissolve 0.300 g in 70 mL of alcohol R and add 1 mL of 0.1 M hydrochloric acid. Carry out a potentiometric titration (2.2.20), using 0.1 M sodium hydroxide. Read the volume between the 2 points of inflexion.

1 mL of 0.1 M sodium hydroxide is equivalent to 41.26 mg of C14H21Br2ClN2.

STORAGE

Protected from light.

IMPURITIES

Specified impurities   A, B, C, D.

Other detectable impurities (the following substances would, if present at a sufficient level, be detected by one or other of the tests in the monograph. They are limited by the general acceptance criterion for other/unspecified impurities and/or by the general monograph Substances for pharmaceutical use (2034). It is therefore not necessary to identify these impurities for demonstration of compliance. See also 5.10. Control of impurities in substances for pharmaceutical use): E.

bp2013_v1_07_medicinal_and_pharmaceutical_substances_02 bromhexinehydrochloride_2_2012_70_cs.png


A. R = CH2OH: (2-amino-3,5-dibromophenyl)methanol,

B. R = CHO: 2-amino-3,5-dibromobenzaldehyde,

bp2013_v1_07_medicinal_and_pharmaceutical_substances_02 bromhexinehydrochloride_3_2012_70_cs.png


C. R = H: N-(2-aminobenzyl)-N-methylcyclohexanamine,

D. R = Br: N-(2-amino-5-bromobenzyl)-N-methylcyclohexanamine,

bp2013_v1_07_medicinal_and_pharmaceutical_substances_02 bromhexinehydrochloride_4_2012_70_cs.png


E. (3RS)-6,8-dibromo-3-cyclohexyl-3-methyl-1,2,3,4-tetrahydroquinazolin-3-ium.

Ph Eur